Get my own profile
Public access
View all15 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Frank SchuhmacherMax-Planck-Institute of Colloids and InterfacesVerified email at mpikg.mpg.de
- Christian SiebenGroup Leader, Helmholtz Center for Infection ResearchVerified email at helmholtz-hzi.de
- Adam D. J. CalowHull, Durham, Max Planck, BristolVerified email at pharmaron-uk.com
- Leif Erik Sander, MDDepartment of Infectious Diseases & Respiratory Medicine Charité - Universitätsmedizin BerlinVerified email at charite.de
- Heung Sik HahmUpptheraVerified email at uppthera.com
- Sebastian GötzeHelmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS)Verified email at helmholtz-hips.de
- Ryan P. SweeneyThe University of AlbertaVerified email at ualberta.ca
- Jonas HanskeScitarisVerified email at scitaris.com
- Christoph RademacherProfessor for Molecular Drug Targeting, University of Vienna, Department of Pharmaceutical SciencesVerified email at univie.ac.at
- Eike-Christian WamhoffBioNTech SEVerified email at biontech.de
- Robert WawrzinekCutanos GmbH | University of Vienna | MPI CI | University of Queensland | Potsdam UniversityVerified email at univie.ac.at
- Ryan KarimiUniversity of TorontoVerified email at mail.utoronto.ca